Tuesday, June 12, 2012 3:15:40 PM
http://seekingalpha.com/article/654451-should-you-buy-synacor?source=email_rt_article_readmore&ifp=0
Conclusion
Unlike BroadVision, Syncor is a real promising company. It is well positioned, profitable, fast growing, and has several good growth opportunities in front of it. It has no debt either. However, much of the growth of the coming one or two years is already priced into the shares at $13, so we think the shares are expensive at the moment. Rather than an outright buy we think it offers an interesting trading opportunity between $9 and $13-4.
One might also want to keep in mind that the promotional efforts of Lebed and the NIA have been going on for some time, while we don't expect anywhere near the downdraft that happened to BroadVision when these efforts stopped, some retreat is to be expected when that happens.
Recent SYNC News
- Syncona Limited Director/PDMR Shareholding • RNS Regulatory News • 06/26/2024 10:37:25 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/26/2024 06:00:05 AM
- Syncona Chair & CEO Hollowood buys GBP100,000 in shares • Alliance News • 06/25/2024 11:56:56 AM
- Syncona Limited Director/PDMR Shareholding • RNS Regulatory News • 06/25/2024 06:00:09 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/25/2024 06:00:05 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/24/2024 06:00:05 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/21/2024 06:00:06 AM
- Syncona swings to annual profit despite challenging market conditions • Alliance News • 06/20/2024 09:22:33 AM
- Syncona Limited Syncona adds two oncology companies to portfolio • RNS Regulatory News • 06/20/2024 06:00:09 AM
- Syncona Limited Final Results • RNS Regulatory News • 06/20/2024 06:00:08 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/20/2024 06:00:04 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/19/2024 06:00:07 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/18/2024 06:00:06 AM
- Syncona to invest GBP40 million into newly created Spur Therapeutics • Alliance News • 06/17/2024 12:15:45 PM
- Syncona Limited Creation of Spur Therapeutics • RNS Regulatory News • 06/17/2024 11:05:00 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/17/2024 06:00:08 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/14/2024 06:00:08 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/13/2024 06:00:05 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/12/2024 06:00:07 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/11/2024 06:00:05 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/10/2024 06:00:06 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/07/2024 06:00:06 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/06/2024 06:00:06 AM
- Syncona Limited Quell provides clinical updates on QEL-001 • RNS Regulatory News • 06/05/2024 06:00:10 AM
- Syncona Limited Transaction in Own Shares • RNS Regulatory News • 06/05/2024 06:00:06 AM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM